Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Int J Mol Sci ; 20(7)2019 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-30925687

RESUMEN

p300/CBP-associated factor (PCAF), a histone acetyltransferase, is involved in many cellular processes such as differentiation, proliferation, apoptosis, and reaction to cell damage by modulating the activities of several genes and proteins through the acetylation of either the histones or transcription factors. Here, we examined a pathogenic role of PCAF and its potential as a novel therapeutic target in the progression of renal tubulointerstitial fibrosis induced by non-diabetic unilateral ureteral obstruction (UUO) in male C57BL/6 mice. Administration of garcinol, a PCAF inhibitor, reversed a UUO-induced increase in the renal expression of total PCAF and histone 3 lysine 9 acetylation and reduced positive areas of trichrome and α-smooth muscle actin and collagen content. Treatment with garcinol also decreased mRNA levels of transforming growth factor-ß, matrix metalloproteinase (MMP)-2, MMP-9, and fibronectin. Furthermore, garcinol suppressed nuclear factor-κB (NF-κB) and pro-inflammatory cytokines such as tumor necrosis factor-α and IL-6, whereas it preserved the nuclear expression of nuclear factor erythroid-derived 2-like factor 2 (Nrf2) and levels of Nrf2-dependent antioxidants including heme oxygense-1, catalase, superoxide dismutase 1, and NAD(P)H:quinone oxidoreductase 1. These results suggest that the inhibition of inordinately enhanced PCAF could mitigate renal fibrosis by redressing aberrant balance between inflammatory signaling and antioxidant response through the modulation of NF-κB and Nrf2.


Asunto(s)
Antiinflamatorios/uso terapéutico , Inflamación/tratamiento farmacológico , Enfermedades Renales/tratamiento farmacológico , Factor 2 Relacionado con NF-E2/inmunología , FN-kappa B/inmunología , Terpenos/uso terapéutico , Factores de Transcripción p300-CBP/antagonistas & inhibidores , Animales , Antiinflamatorios/farmacología , Fibrosis , Inflamación/inmunología , Inflamación/patología , Riñón/efectos de los fármacos , Riñón/inmunología , Riñón/patología , Enfermedades Renales/inmunología , Enfermedades Renales/patología , Masculino , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacos , Terpenos/farmacología , Factores de Transcripción p300-CBP/inmunología
2.
J Transl Med ; 13: 203, 2015 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-26116070

RESUMEN

BACKGROUND: Anthocyanins are major constituents of food colours and have been reported to possess anti-diabetic activities for potential medicinal use. The precise role of anthocyanins in diabetic nephropathy is poorly understood. We investigated whether anthocyanin-rich Seoritae extract (SE) can potentially prevent oxidative stress and lipotoxicity, which are the main causes of renal damage in diabetic nephropathy, via activation of AMP-activated protein kinase (AMPK) and the consequent effects on its target molecules. METHODS: Four groups of male C57BLKS/J db/m and db/db mice were used. Diabetic and non-diabetic mice were orally administered 10 mg/kg body weight SE daily for 12 weeks, starting at 8 weeks of age. RESULTS: db/db mice treated with anthocyanins showed decreased albuminuria. Anthocyanins ameliorated intra-renal lipid concentrations in db/db mice with improvement of glomerular matrix expansion and inflammation, which was related to increased phosphorylation of AMPK and activation of peroxisome proliferator-activated receptor (PPAR) α and PPARγ, and inhibited the activity of acetyl-CoA carboxylase and sterol regulatory element-binding protein 1. Anthocyanins reversed diabetes-induced increases in renal apoptosis and oxidative stress. In cultured human glomerular endothelial cells, anthocyanins prevented high glucose-induced oxidative stress and apoptosis through activation of AMPK in the same manner. CONCLUSIONS: The results revealed that anthocyanins ameliorated diabetic nephropathy in db/db mice via phosphorylation of AMPK, the major energy-sensing enzyme, and the consequent effects on its target molecules, which appeared to prevent lipotoxicity-related apoptosis and oxidative stress in the kidney.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Antocianinas/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Enfermedades Renales/tratamiento farmacológico , Riñón/patología , Lípidos/toxicidad , Extractos Vegetales/uso terapéutico , Animales , Antocianinas/farmacología , Apoptosis/efectos de los fármacos , Colesterol/metabolismo , Colágeno Tipo IV/metabolismo , Diabetes Mellitus Experimental/enzimología , Diabetes Mellitus Experimental/patología , Dinoprost/análogos & derivados , Dinoprost/orina , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Células Endoteliales/patología , Activación Enzimática/efectos de los fármacos , Ácidos Grasos/metabolismo , Humanos , Riñón/efectos de los fármacos , Riñón/enzimología , Enfermedades Renales/enzimología , Enfermedades Renales/patología , Masculino , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacos , Fenotipo , Fosforilación/efectos de los fármacos , Extractos Vegetales/farmacología , Glycine max/química , Factor de Crecimiento Transformador beta/metabolismo , Triglicéridos/metabolismo , Proteína X Asociada a bcl-2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA